Biobank for people using phage therapy
Part of Infections clinical trials.
This study collects and stores samples (a “biobank”) from adults who plan to receive or have already received phage therapy. It helps researchers better understand how phage therapy works and can support future treatment research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Be able to understand the study and sign consent (informed consent)
- Have a planned future phage therapy treatment, or have received phage therapy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
This trial tests a virus-based treatment (bacteriophage) for a chronic joint infection caused by a specific bacteria that hasn't responded to other treatments.
This trial tests whether bacteriophages—viruses that kill bacteria—can help treat a chronic lung infection caused by a drug-resistant bacterium called Mycobacterium abscessus.
This study looks at how well phage therapy (a virus that kills bacteria) works for severe infections. It's for people who received this treatment at a specific hospital in France.
This study checks the safety of using phage therapy (viruses that target certain bacteria) in adults being treated for serious infections. If you meet the safety rules, your care team may enroll you to help confirm phage treatment is safe.
This trial is an organized clinic to help patients request bacteriophage (phage) therapy. It mainly checks that you were referred to the Lyon hospital for a phage therapy request and that you agree to be part of the program.
Hear when a new Bacteriophage Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.